Normal ovarian development is crucial for female reproductive success and longevity. Interruptions to the delicate process of initial folliculogenesis may lead to ovarian dysfunction. We have previously demonstrated that an early life immune challenge in the rat, induced by administration of lipopolysaccharide (LPS) on postnatal day (PND) 3 and 5, depletes ovarian follicle reserve long term. Here, we hypothesized that this neonatal immune challenge leads to an increase in peripheral and ovarian inflammatory signaling, contributing to an acute depletion of ovarian follicles. Morphological analysis of neonatal ovaries indicated that LPS administration significantly depleted PND 5 primordial follicle populations and accelerated follicle maturation. LPS exposure upregulated circulating interleukin 6, tumor necrosis factor alpha (TNFa), and C-reactive protein on PND 5, and upregulated ovarian mRNA expression of Tnfa, mitogen-activated protein kinase 8 (Mapk8/Jnk1), and growth differentiation factor 9 (Gdf9) (P < 0.05). Mass spectrometry and cell signaling pathway analysis indicated upregulation of cellular pathways associated with acute phase signaling, and cellular survival and assembly. Apoptosis assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling indicated significantly increased positive staining in the ovaries of LPS-treated neonates. These findings suggest that increased proinflammatory signaling within the neonatal ovary may be responsible for the LPS-induced depletion of the primordial follicle pool. These findings also have implications for female reproductive health, as the ovarian reserve is a major determinate of female reproductive longevity. A. Fuller et al., 2017, Vol. 97, No. 5 
Introduction
Despite significant medical advances, idiopathic infertility and the prevalence of reproductive disorders in younger female cohorts is increasing [1] [2] [3] [4] . As the fundamentals of reproductive health and longevity are established in early life, the pathogenesis of female reproductive dysfunction may have developmental roots. Abnormalities occurring during this critical period of development may lead to sustained ovarian pathophysiology, including premature ovarian failure (POF) and other fertility issues [5] [6] [7] . Recent evidence indicates that the female reproductive system is sensitive to early life stressors, such as xenobiotics, infections, and malnutrition, which can perturb reproductive development and negatively impact long-term fertility levels [8] [9] [10] [11] [12] .
Mammalian female reproductive health and success is reliant on the normal establishment of the nonrenewing ovarian primordial follicle reserve, which is the foundation of all future follicles and determines the reproductive lifespan [as reviewed in 13, 14] . This initial folliculogenesis occurs prenatally in humans, however finalizes during the first postnatal week in rodents. Early follicles containing oocytes ultimately develop from the primordial stage through to the ovulatory stage, until the reserve is diminished and menopause, or senescence in rats, occurs [15] . Initial folliculogenesis is governed by numerous mechanisms that remain to be fully elucidated; however, current evidence indicates that complex interactions of chemokines, cytokines, neurotrophins, growth factors, and transcription factors mediate the bidirectional communication between the oocyte and its supporting granulosa cells [16] [17] [18] [19] . This oocyte-granulosa crosstalk controls the quiescence, activation, and maturation of the primordial follicular pool to regulate both the quantity and quality of the ovarian reserve [20, 21] . Variation or perturbation to these delicate developmental processes, via immune activation for example, can potentially lead to sustained changes in ovarian development, and overall reproductive health [6, 22] .
Immune activation is a common perinatal environmental stressor that is modeled experimentally using gram-negative bacterial mimetic, lipopolysaccharide (LPS). LPS provokes an innate immune response by binding to toll-like receptor-4 (TLR4). This instigates a proinflammatory cascade via activation of nuclear factor kappa beta (NFkB) and mitogen-activated protein kinase (MAPK) pathways, and the subsequent secretion of proinflammatory cytokines interleukin (IL) 6, IL1beta (B), tumor necrosis factor alpha (TNFa), C-reactive protein (CRP), and interferon gamma (IFNy) from activated macrophages and immune cells [23, 24] . Animal models of neonatal immune stress via LPS exposure have demonstrated a broad range of long-term physiological and behavioral alterations, including neuroendocrine dysfunction, brain morphological alterations, and innate immune system dysfunction [25] [26] [27] [28] .
The ovary expresses innate immune cells including monocytes, macrophages, and adipocytes [29] . Additionally, cytokines and their receptors, and TLRs are locally expressed in ovarian cells and participate in immune functioning essential to ovarian processes [30, 31] . Importantly, LPS exposure has been demonstrated to detrimentally affect female reproductive outcomes [32, 33] including premature puberty and senescence onset, downregulation of hypothalamicpituitary-gonadal hormone expression, and impairments in mating and maternal behaviors [8, 11, 26, 34, 35] . Moreover, neonatal and adulthood LPS exposure has been demonstrated to lead to in vitro follicular atresia, reduced prepubertal ovarian follicle reserve, and upregulated ovarian TLR4 expression [36] [37] [38] . Taken together, these findings suggest that early life LPS exposure produces sustained detrimental effects on ovarian functioning.
To date, little research has focused on the acute in vivo impact of early life immune activation on ovarian morphology and inflammation. Previous studies from our laboratory indicate ovarian inflammatory pathway activation on postnatal day (PND) 7 from LPS administration at PNDs 3 and 5 [37] , but none to our knowledge have examined the immediate effect of this LPS exposure. Considering the importance of immune involvement for ovarian development and continuing reproductive health [29] , the current study aims to examine the acute inflammatory mediators activated by neonatal administration of LPS and associated growth and transcription factors that may underpin the sustained ovarian morphological and behavioral reproductive alterations seen previously in our laboratory with this model, including the early onset of reproductive senescence in female rats, indicated by premature cessation of oestrus cycling [11] . Given that our PND 3 and 5 model of neonatal immune activation falls within the critical period of ovarian development and sensitivity to immune stress for the rodent ovary [35] , we propose that LPS exposure may directly perturb the critical, gonadotropin-independent final stages of neonatal primordial folliculogenesis via excessive immune stimulation occurring both at a systematic and local level.
Methods

Animals and neonatal immune challenge
All animal experimental procedures were undertaken with the approval of the University of Newcastle Animal Care and Ethics Committee (ACEC, A-2012-2813). Twenty-one experimentally naïve female Wistar rats were obtained from the University of Newcastle animal house and mated with proven male studs in the Laboratory of Neuroimmunology Vivarium. This resulted in 18 litters and a total of 62 female pups used for this study. Animals were maintained under normal housing conditions at 21
• C-22
• C on a 12-h light/dark cycle (0600-1800) with food available ad libitum. As previously described [11, 26-28, 37, 39] , at birth (PND 1) whole litters were randomly allocated to treatment conditions, either LPS (derived from 10 litters) or saline (derived from eight litters). Whole litters were exposed to LPS (Salmonella enterica, serotype Enteritidis: Sigma-Aldrich Chemical Co., USA in sterile pyrogen-free saline, 0.05 mg/kg) or saline (equivolume; Livingstone International, Australia) on PND 3 and again on 5. This low dose and timing of LPS administration has been demonstrated in our laboratory and others to elicit a rapid, sustained, and controlled immune and endocrine response during a critical developmental period, without inducing mortality seen at higher doses [26, 28, 37, [39] [40] [41] [42] [43] . Briefly, pups were temporarily removed from the home cage and transferred to an incubator to maintain body temperature, weighed, administered with an intraperitoneal injection of LPS or vehicle, and then returned to the home cage/dam.
Blood and tissue collection
Female pups were euthanized by rapid decapitation. A subset of female animals were culled on PND 3 for analysis of ovarian morphology (n = 6 per group derived from three litters per group). The remaining females were euthanized on PND 5, at 2 h following the last neonatal injection, as this has been demonstrated to be the optimal time point for peripheral, central, and genetic cytokine expression following LPS [44, 45] . PND 5 trunk blood was collected into ethylenediaminetetraacetic acid-coated tubes and centrifuged for 20 min at 1000g. Plasma was collected and stored at -20
• C for assessment of plasma cytokine levels. Ovaries were dissected with fine tip forceps in 4
• C sterile phosphate-buffered saline (PBS, Sigma)
under a dissection microscope, where all surrounding tissue was removed. One ovary from a subset of animals was randomly chosen and placed in Bouins fixative for histological examination (PND 5; n = 6 LPS, 6 saline, derived from three to four litters per group).
Remaining ovaries were snap-frozen on dry ice, and stored at -80
All remaining tissue was randomly pooled within treatment conditions to create sufficient tissue for biological samples and allocated to either real-time quantitative (qRT)-PCR or proteomic analysis. Male and female animals remaining in litters were allocated to other experiments.
Blood analysis for peripheral inflammatory cytokines PND 5 plasma was analyzed by ELISA according to the manufacturer's instructions for proinflammatory markers IL6 (Abcam, ab119548 rat ELISA kit, minimum detection rate 12 pg/mL, intraand interassay variability <5% and <10% respectively), TNFa (R&D Systems Rat TNF alpha Quantikine ELISA Kit, RTA00, minimum detection rate <5 pg/mL, intra-and interassay variability 2.1%-5.1% and 8.8%-9.7% respectively), and CRP (Abcam, ab108827, minimum detection rate 0.7 ng/mL, intra-and interassay variability 3.8% and 9.6%, respectively). Each ELISA contained biological samples from at least three different litters per treatment group, with n = 6-12 per group. All samples were assayed in duplicate. .1% formic acid) at 500 nL/min over an 80 min period. The liquid chromatography eluent was subject to positive ion nanoflow electrospray mass spectrometry (MS) analysis on QSTAR that was operated in an information dependent acquisition mode (IDA). In IDA mode, a TOFMS (time of flight mass spectrometry) survey scan was acquired (m/z 400-1600, 0.5 s), with the three largest multiply charged ions (counts >25) in the survey scan sequentially subjected to MS/MS analysis. MS/MS spectra were accumulated for 2 s (m/z 100-1600). The data were processed using the database search program, Mascot (Matrix Science Ltd, London, UK) with peaklists searched against Rattus in the SwissProt database [47] . High scores in the database search indicate a likely match that was confirmed or qualified by operator inspection. Search results were generated with a significance threshold of P < 0.05 with an ion score cut-off of 25 for all samples. This work was undertaken at APAF, the infrastructure provided by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS). LPS and saline groups were compared and Ingenuity Pathway Analysis (IPA: Ingenuity Systems, Redwood City, CA) software was used to identify top canonical signaling protein pathways and upstream regulators affected by neonatal treatment.
Histological evaluation of ovarian follicles
RNA extraction, reverse transcription and real-time quantitative-PCR
In order to isolate sufficient quantity and quality mRNA from whole PND five ovaries, six to eight ovaries from the same treatment group were randomly pooled within treatment groups to create biological replicates. Total RNA was isolated from ovaries using a modified acid guanidinium thiocyanate-phenol-chloroform protocol, followed by an isopropanol precipitation as previously described [48, 49] and DNase treated prior to reverse transcription for the removal of genomic DNA. Reverse transcription was performed as outlined in Sobinoff et al. [48] with 2 μg of total isolated RNA, 500 ng oligo(dT), 15 μg of primer (FWD and REV), 40 μg of RNasin, 0.5 mM dNTPs, and 20 μg of M-MLV-Reverse Transcriptase (Promega; Madison, WI, USA). Reverse transcription reactions were verified by Actin beta (Actb) or Cyclophilin qPCR using cDNA amplified with GoTaq Flexi (Promega). Quantitative RT-PCR was performed in 20 μl reactions using SYBR Green GoTaq qPCR master mix (Promega) according to manufacturer's instructions on a LightCycler 96 SW 1.0 (Roche, Castle Hill, NSW, Australia) for transcription factor Forkhead box O3a (Foxo3a) and growth differentiation factor 9 (Gdf9), as well as Forward and reverse sequence and efficiency for target genes analyzed involved in early ovarian follicular control and development, and inflammation.
inflammatory markers; Tnfa, mitogen-activated protein kinase 8/Jun N-terminal kinase (Mapk8/Jnk1), protein kinase C beta (Prkcb) and Tlr4. These markers are associated with both LPS-activated inflammatory pathways and are essential to steroidogenesis during this critical time point in gonadotropin-independent ovarian development, as well as continued ovarian-immune functioning throughout the lifespan [18, [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] . Gene and protein markers assessed were chosen to reflect the nature and timing of our early life immune stress exposure model, based on previous research from our laboratory [37] and in line with broad proteomic identification of factors in the current study associated with ovarian cell proliferation, migration, apoptosis, and LPS-induced inflammation (see Supplementary  Table S5 ). Each sample was accompanied by a RT-negative replicate as a negative control. Quantitative RT-PCR data were normalized to the housekeeping control gene Cyclophilin as per Sutherland et al. [49] and analyzed using the comparative C T method equation 2 − C(t) (where C(t) is the threshold cycle at which fluorescence is first detected as statistically significant above background) and presented as a fold increase relative to the saline control group [61] . Experiments were replicated a minimum of three times prior to statistical analysis, with all PCR performed on at least three separate tissue isolations/biological replicates [as per 62]. Primer sequences are supplied (Table 1) and were optimized by qPCR both here and previously [37] .
Immunohistochemistry
Immunohistochemistry was used to localize TNFa protein and DNA damage via Phosphorylated histone gamma H2AX (yH2AX) expression. Caspase 3 (CASP3) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were used to quantify apoptosis. TLR4 localization was assessed to confirm LPS activation via TLR4 binding in the neonatal ovary. TNFa was localized in PND 5 ovarian tissue using a Vector 3, 3-diaminobenzidine (DAB) peroxidase substrate kit (Vector Laboratories, Burlingame, CA, USA) following manufacturer's instructions. Slides were deparaffinized in xylene and rehydrated in ethanol washes. Antigen retrieval was carried out in preheated Na citrate buffer (10 mM, pH 6), microwaved for 12 min. Endogenous peroxidase quenching was performed (0.3%) for 20 min; slides were rinsed in PBS-TX and blocked in 3% bovine serum albumin (BSA) in PBS for 1 h. Slides were incubated with primary antibody overnight at 4
• C (anti- Table S1 for antibody information and Supplementary Table S6 for immunohistochemical control imaging). TUNEL positive cells were quantified by an experimenter blind to treatment conditions. CASP3 corrected total cell florescence (CTCF) was measured in Image J (National Institutes of Health, MD, USA) and calculated using the formula CTCF = integrated density -(area of selected section × mean fluorescence of background readings) [63] .
Statistical analysis
Data were analyzed using IBM SPSS statistics (Version 24, IBM Australia) with a two-way analysis of covariance design, repeated measures analysis of variance, and student independent t-test where appropriate, with pairwise comparisons between treatment groups carried out using the Bonferroni correction. Where covariates including litter size, body weight, and male-to-female ratio did not significantly impact dependent variables, they were removed from the analysis to maximize statistical power. Statistical assumption violations were corrected by a log10 transformation (IL6 only). Data are presented here as the mean + standard error of the mean (SEM).
Significance was assumed at P ≤ 0.05.
Results
Neonatal weight gain
No significant weight difference was observed between treatment groups on PND 3 or PND 5; however, LPS females gained significantly less weight between PND 3 and 5 compared to controls (neonatal treatment × age: F (1, 57) = 42.02, P ≤ 0.0001; pairwise contrast: t(43) = 4.5, P < 0.0001; Figure 1A ). An expected significant main effect of age (F (1, 57) = 105.49, P < 0.0001) was also observed, with PND 5 animals weighing more than PND 3 animals.
Impact of lipopolysaccharide on peripheral inflammatory markers on postnatal day 5
As anticipated, circulating CRP, IL6, and TNFa was significantly upregulated in LPS-treated animals compared to controls (F (1, 17) = 11.782, P = 0.003 [ Figure 1B ], F (1, 15) = 10.47, P = 0.006 [ Figure 1C ], F (1, 24) = 4.71, P = 0.04 [ Figure 1D ], respectively).
Impact of lipopolysaccharide on early ovarian follicle pool
On PND 5, LPS-treated animals had significantly reduced primordial follicles compared to saline controls (t (10) = 4.02 P = 0.002, Figure  2A ; neonatal treatment effect: F (1, 20) = 18.78, P < 0.001; neonatal treatment × age effect: F (1, 20) = 10.90, P = 0.004). Neonatal LPS exposure altered the quantity of activated primordial follicles, with reduced numbers of follicles in LPS-treated rats compared to saline controls on PND 3 (t (10) = 2.39, P = 0.03, Figure 2B ), but significantly increased activated primordial follicles on PND 5 (t (10) = 2.31, P = 0.044); age × treatment effect: F (1, 20) = 10.97, P = 0.003; Figure 2B ). There were no significant differences in primary follicle numbers on either treatment day ( Figure 2C ). As expected, a significant effect of age was seen on all follicle types 
Impact of lipopolysaccharide on ovarian proteome
There was significant expression of 598 proteins in the ovaries of PND 5 LPS females (P ≤ 0.05). Protein expression was compared to saline control levels, resulting in 29 proteins differentially expressed in LPS-treated animals. Functional analysis of these identified several molecular networks, canonical pathways and cellular functions implicated in acute phase response signaling and innate immune responses, amino acid and lipid metabolism, molecular transport, and cellular movement, signaling, assembly and survival (Figure 3A and B; Supplementary Tables S2-S5) .
Ovarian real-time quantitative-PCR PND 5 ovaries were probed for mRNA expression of proinflammatory markers and growth and transcription factors. Fold-change mRNA expression of Gdf9 was significantly upregulated in the ovaries of PND 5 LPS-treated females (t (4) = 8.05), compared Blue bars (column graph, x-axis) represent the significance of associated upregulated expressed proteins and the canonical pathway assessed using a right-tailed Fisher's exact test to calculate p-values determining the probability that the association is explained by chance alone. Ratio score (line graph, z-axis) indicates the proportion of coverage from a pathway related to total number of molecules, subject to pathway size bias.
to saline controls, P ≤ 0.001 ( Figure 4A ). There were no significant changes in expression of Foxo3a ( Figure 4B ). We observed a trend towards downregulated Tlr4 mRNA expression in LPS-treated animals (P = 0.061) ( Figure 4C ). Expression of Tnfa and Mapk8/Jnk1 were significantly upregulated in LPS-treated animals on PND 5 (t (4) = 3.54 and t (4) = 0.14, respectively; both P ≤ 0.05) ( Figure  4D and E). LPS females displayed a nonsignificant increase in Prkcb mRNA expression (P = 0.170, Figure 4F ).
Ovarian protein localization and quantification
Immunohistochemical processing was carried out on the PND 5 ovaries of LPS and saline-treated females to detect the localized expression of TLR4 and TNFa protein, yH2AX as a marker of doublestranded DNA damage, and cleaved CASP3 and TUNEL for assessment of apoptosis. Gamma H2AX was detected in oocytes of both LPS and saline animals ( Figure 5A and B). TLR4 immunolabeling was detected surrounding the oocyte ( Figure 5C and D). Tumor necrosis factor alpha expression was detected both in the granulosa cells and oocytes in both treated and control samples ( Figure 5E and F). CASP3 quantification in the ovaries of LPS-treated animals demonstrated a 2.3× fold change increase in CTCF compared to saline-treated controls. However, this increase was not statistically significant (t (4) = 2.291, P = 0.084 [ Figure 6A -C]). LPS-treated animals demonstrated a significantly greater number of TUNEL positive ovarian cells (t (4) = 5.191, P = 0.007, particularly in oocytes [ Figure  6D -F]).
Discussion
Early life is a critical period for fundamental ovarian development and associated neuroendocrine and immune system maturation. Disruption of developmental trajectories via immune activation during this sensitive period may have persisting detrimental effects. Here, we demonstrate in female neonatal rodents that a low dose of LPS in the first week of life has an acute effect on the neonatal ovary during the final stages of follicular pool formation in vivo. LPS administration on PND 3 and 5 upregulated circulating inflammatory mediators, altered early follicle populations, and had an immediate effect on ovarian immune status on PND 5. This study is one of the first to show the immediate effect of perinatal immune stress on early ovarian follicle populations and associated ovarian transcriptome. Neonatal LPS exposure resulted in reduced weight gain between PND 3 and PND 5, consistent with our previous findings [11, 27, 28] . As expected, administration of LPS on PND 3 and 5 caused significant increases in circulating acute phase protein CRP, IL6, and TNFa. These results confirm the efficacy of LPS treatment in what is considered a hypo-responsive period for immune responses and stress in the neonatal rodent [64, 65] . Peripheral increases in proinflammatory cytokines may stimulate and exacerbate normal inflammatory mediator levels within the ovary at this critical time, regardless of ovarian immune privilege.
Neonatal LPS exposure altered early follicle populations in the PND 5 ovary, leading to a significant decrease in primordial follicle numbers and a significantly greater number of activated primordial follicles. This suggests that early life immune activation may prematurely activate quiescent follicles, leading to follicle depletion. Previous findings from our laboratory demonstrated a depleted PND 14 primordial follicle pool [37] , as well as advanced senescence at 1 year of age [11] , indicating that the morphological changes seen here are sustained through to prepubescence and may contribute to an early fertility decline. Premature follicle diminishment reduces the number of viable follicles for later ovulation, in turn affecting the quality of the dominate follicle. The untimely depletion of primordial follicle pool seen here may be occurring via intraovarian autocrine and paracrine immune signaling [66] or via gap junctions operating within the oocyte-granulosa cell complex [67] , stimulated by excessive immune perturbation. Rapid follicle formation, proliferation, maturation, and atresia is typical in the PND 2 to 5 female rodent, where oogonia migration is occurring [15] . LPS administration may exacerbate these typical ovarian processes, particularly as LPS stimulation has been demonstrated to cause oocyte and granulosa cell apoptosis in fully developed ovaries [36, 68] . This is substantiated in the current study by the localization of yH2AX in the oocyte complex, indicative of rapid DNA damage [69] , and the significant increase in TUNEL positive oocytes in LPS-treated animals, demonstrating a combined effect of PND 3 and PND 5 LPS injections. Primary follicle populations did not differ, suggesting that primordial follicles may have already undergone apoptosis postactivation, and that the primordial follicle population may have a heightened vulnerability to the effects of LPS. Likewise, Bromfield and Sheldon [36] demonstrated that the primordial follicle pool is particularly sensitive to LPS-driven apoptosis, whereas larger follicles display some resilience. Using MS, we identified 29 proteins differentially expressed in the PND 5 ovaries of LPS-treated animals. Pathway analyses indicated that these proteins were associated with acute-phase response signaling, liver X receptor/retinoic X receptor (LXR/RXR) activation, mechanism of viral exit, and glycogen degradation signaling (see Figure 3 ; Supplementary Tables S2-S5 ). This indicates transcription of acute phase mediators within the PND 5 ovary, confirmed here with qRT-PCR. These results are congruent with our previous microarray findings demonstrating LPS stimulated upregulation of immune pathways in PND 7 ovaries [37] . Activation of the LXR/RXR pathway is of novel interest, as LXR/RXRs are involved in the macrophage response to TLR4 activation and are expressed in the ovary [70, 71] , with LXR null mice displaying subfertility and oocyte meiotic incompetence [72] . Interestingly, LXR/RXR activation inhibits inflammatory signaling [73] ; hence, activation of LXR/RXR seen here may serve to protect the developing ovary from excessive inflammation. Further investigation is needed as this may be a novel pathway to examine in the early life immune stress model, particularly considering the association between early life stress, fertility dysfunction, and metabolic and inflammatory diseases.
In the current study, LPS administration significantly upregulated the mRNA expression of inflammatory mediators MAPK8/JNK1 and TNFa in the ovaries of LPS-treated animals on PND 5. MAPK8/JNK1 signaling is a major component in acute phase responses, cell survival and apoptosis [60] and both LPS and proinflammatory cytokines, particularly TNFa, activate the MAPK8/JNK1 pathway [74, 75] . The MAPK8/JNK1 pathway is also implicated in the activation and maturation of early follicles [60, 76] . Recent evidence indicates MAPK8/JNK signaling contributes to follicle activation via the mechanistic target of rapamycin signaling, which may merit further investigation within the current model [77] . The significantly increased expression seen here may indicate that a downstream acute phase response is activated within the ovary, with immune mechanisms contributing to early follicle depletion. Concomitant to MAPK8/JNK1 stimulation, is the activation of other inflammatory pathways and mediators including NFKB, PI3K/AKT, PKCB, IL1B, IL6, nitric oxide synthase-1 (NOS2), and cyclooxygenase-2 [78] , which are all associated with both normal and pathological ovarian function [66, [79] [80] [81] [82] , and early life activation of MAPK pathways may lead to long-term functional differences with these mediators. It is known that TNFa activates and exacerbates the LPS-driven immune and stress responses, and plays a fundamental role in the immature ovary, facilitating normal oocyte atresia and follicular assembly to define the size of the primordial follicle pool [58, 83] . As TNFa alone can impair ovarian functions and override factors that inhibit follicle activation [59, 84] , these higher gene expression levels of Tnfa seen here may be a driving factor increasing primordial follicle activation in LPS-treated animals, leading to superfluous and premature depletion. Tumor necrosis factor alpha protein was localized to granulosa cells, oocytes, and the surrounding complex in both groups, indicating that expression may be facilitating bidirectional crosstalk between the oocyte-granulosa matrixes. The strong trend for Tlr4 downregulation seen here is most probably due to a habituation effect of the temporal proximity of dual LPS administration and the time point at which tissue was taken. These findings were contrary to those hypothesized, as we previous demonstrated a significant upregulation of Tlr4 gene expression in the PND 7 ovary; however, TLR4 staining here was localized to the oocyte cytoplasm as previously demonstrated [37] . The current and previous findings suggesting that the ovary may adapt to the level of LPS signaling and display altered TLR4 expression as a way to manage a predicted high-immune-stress or bacterialrich environment. Permanent alterations in TLR4 expression may be detrimental, particularly considering that TLR4 overexpression is involved in the growth and survival of ovarian cancer cells [85] and poor ovarian response [86] , and TLR4 under expression is implicated in polycystic ovarian syndrome (PCOS) and endometriosis [87, 88] . Protein kinase C beta aids the regulation of early follicular proliferation, survival, and activation [89] , and although upregulation here is nonsignificant, it may be contributing to the perpetuation of cytokine secretion [90] .
Growth factor GDF9 and transcription factor FOXO3A are implicated in early follicle primordial growth, maturation, and apoptosis. The significantly increased Gdf9 mRNA expression demonstrated here may indicate that immune activation is prematurely instigating the maturation signaling between the oocyte and its granulosa cells, particularly as GDF9 stimulates small follicle proliferation of granulosa cells in rats in vivo [91, 92] and promotes growth of human ovarian follicles in vitro [93] . Abnormal expression of GDF9 and Gdf9 mutations of are apparent in women with PCOS and POF [53, 94] . Additionally, the Gdf9 increases seen here may also be an attempt to downregulate inflammation, as Gdf9 activation stimulates transforming growth factor (TGF)-beta-like SMAD2/3 intracellular pathways [95] that have been shown to inhibit immune cells, including macrophage activation, with LPS exposure [96] . As macrophages that express TLR4 are present in the ovary, the increase in Gdf9 expression in LPS challenged animals may indicate a protective mechanism undertaken by the ovary in order to self-modulate inflammatory signaling, with activation and atresia of some early follicles being compensation for overall ovarian reserve defense. Neonatal immune insults may not only impact the quantity, but also the long-term quality of the remaining follicular pool. As GDF9 and associated TGF-b superfamily members are modulators of sex hormone sensitivity, aberrant GDF9 signaling during ovarian development may have long-term effects on follicle stimulating hormone and luteinizing hormone receptor densities and sensitivities, affecting postpubertal ovarian processes [97, 98] . Forkhead box-O3a has been suggested as a key mediator of naked oocyte and primordial follicle apoptosis within the neonatal rat ovary [56] . As FOXO is negatively regulated by PKB/AKT/PI3K and MAPK8/JNK1 activation [55, 99] , this may be contributing to our unexpected nonsignificant findings as previous findings with this LPS model indicate significant upregulation of Prkb/Akt/Pi3k pathways in PND 7 ovaries [37] . The nonsignificant difference in Foxo3a at this current time point indicates that analysis at an alternate time point is needed to capture Foxo3a translocation, transcription, and apoptosis induction. Forkhead box O3-null mice demonstrate normal follicle assembly, followed by global activation and early depletion of the primordial follicle pool, leading to POF and infertility [100] . This implicates FOXO3A in the maintenance of quiescent follicles, as transgenic models of constitutively active Foxo3a expression demonstrate suppression of follicular maturation and infertility [101] , meriting future investigation in this model. Future studies are necessary to examine FOXO3A and additional growth/transcription factor gene and protein expression in the neonatal LPS model, particularly given the links between FOXO3A and LPS-induced innate inflammatory pathway upregulation, ovarian follicular development, and studies demonstrating LPS inactivating FOXO3A in other tissues [102] [103] [104] . Our current findings indicate that LPS exposure activates and depletes the early primordial follicle pool. This may be occurring via immune pathways to affect transcription and growth factormediated early follicular control, particularly considering the shared, complex immune-regulatory properties and capabilities of TNFa, MAPK8/JNK1, and GDF9. These mediators influence early follicle formation, development, and maintenance during a critical period, where follicle dynamics are both intricate and elusive in nature. The development of the finite ovarian follicular pool is dependent on homeostatic processes, which if disrupted, may lead to sustained alterations to ovarian physiology. Premature loss of the ovarian reserve not only has a detrimental effect on the female reproductive lifespan, but is associated with a myriad of heath complications due to deficiency of ovarian-produced oestrogen, including osteoporosis, cardiovascular disease, autoimmunity, and psychological disorders. Early life stress is already a well-established risk factor for morbidity and mortality from a range metabolic, immune, and neuroendocrine disorders [105] , and is known to lead to a physiological vulnerability to stressors in later life [43, 106] . The pathogenesis of idiopathic reproductive disorders may have developmental origins, as well as be intensified by the additional stress these disorders exert. The current study provides further insight into the link between early life immune disturbances and ovarian development. A number of female reproductive disorders associated with skewed inflammatory profiles such as; PCOS, endometriosis, and POF are increasingly presenting in a younger female demographic, often with no apparent origin. Examining stressful events in the early life environment can therefore provide valuable insight into the pathogenesis and progression of reproductive disorders, as well as aid in the understanding of mechanisms regulating the formation and longevity of the ovarian reserve.
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Supplementary Table S4 . Ingenuity pathway analysis (IPA) information including top networks, top biological functions, top canonical pathways and top upstream regulators for both saline and LPS treatment groups, and molecular pathway visualization links for top LPS pathways.
Supplementary Table S5 . Function/role of the 29 differentially expressed proteins in LPS-treated animals according to immune (IM) and/or ovarian developmental functions (OV) (retrieved from uniprot).
Supplementary data S6. Immunohistochemistry positive and negative control images. (A) Gamma H2AX controls; (B) CASP3 controls; (C) TLR4 controls; (D) TUNEL controls; (E) TNFa DAB controls.
